Info: Zenodo’s user support line is staffed on regular business days between Dec 23 and Jan 5. Response times may be slightly longer than normal.

Published August 16, 2021 | Version v1
Journal article Open

Family History of Head and Neck Cancers

  • 1. Center for Primary Health Care Research, Lund University, 20502 Malmö, Sweden.
  • 2. Department of Otorhinolaryngology-Head and Neck Surgery, Helsinki University Hospital and University of Helsinki, 00029 Helsinki, Finland.
  • 3. Department of Urology, Helsinki University Hospital and University of Helsinki, 00029 Helsinki, Finland. Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00029 Helsinki, Finland.
  • 4. Center for Primary Health Care Research, Lund University, 20502 Malmö, Sweden. Hopp Children's Cancer Center (KiTZ), 69120 Heidelberg, Germany.Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), 69120 Heidelberg, Germany.
  • 5. Center for Primary Health Care Research, Lund University, 20502 Malmö, Sweden. Department of Family Medicine and Community Health, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Center for Community-based Healthcare Research and Education (CoHRE), Department of Functional Pathology, School of Medicine, Shimane University, Izumo, Shimane 693-8501, Japan.
  • 6. Center for Primary Health Care Research, Lund University, 20502 Malmö, Sweden. Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, 30605 Pilsen, Czech Republic. Division of Cancer Epidemiology, German Cancer Research Centre (DKFZ), 69120 Heidelberg, Germany.

Description

BACKGROUND: Head and neck cancers (HNCs) encompass a heterogeneous group of cancers between the mouth and larynx. Familial clustering in HNCs has been described, but how it influences individual sites and to which extent known risk factors, such as human papilloma virus (HPV) infection, may contribute is not well established. PATIENTS/METHODS: We employed standardized incidence ratios (SIRs) to estimate familial risks for HNC with same (concordant) and different (discordant) cancers among first-degree relatives using data from the Swedish Cancer Registry from 1958 to 2018. RESULTS: Incidence for male and female oropharyngeal cancer increased close to four-fold in the past 39 years. Familial HNC was found in 3.4% of the study population, with an overall familial SIR of 1.78. Patients with concordant nasopharyngeal cancer showed a high risk of 23.97, followed by hypopharyngeal cancer (5.43). The husbands of wives with cervical cancer had an increased risk of oropharyngeal cancer. DISCUSSION/CONCLUSION: Nasopharyngeal cancers lacked associations with lifestyle or HPV associated cancers, suggesting a role for germline genetics, which was also true for the high-risk families of three HNC patients. In the Swedish population with low smoking levels, HPV is becoming a dominant risk factor, emphasizing the need for sexual hygiene and HPV vaccination.

Notes

The study was supported by the European Union's Horizon 2020 research and innovation program, grant no. 856620; the Swedish Research Council (2020-01175; 2018-02400); and the ALF project grant, Region Skane/Lund University, Sweden.

Files

598028.pdf

Files (627.6 kB)

Name Size Download all
md5:5748338d6459a42619f1bfc39e1832b2
627.6 kB Preview Download

Additional details

Funding

Chaperon – ERA Chair Position for Excellent Research in Oncology 856620
European Commission